HomeAI · summaries
Storia in 8 fonti
FDA approves smallest single-pill HIV regimen, Bixlenvo
The FDA has approved Bixlenvo, the first single-pill daily HIV therapy for adults being successfully treated on more complex regimens who are unable to take other available single-tablet HIV medications. The accelerated approval was announced by Gilead Sciences, which developed the single-tablet regimen combining two of its existing drugs:
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients
The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new treatment.
- ·
fiercepharma.com
Gilead christens Bixlenvo with FDA nod for new HIV treatment combo tablet
Some 20 years after helping introduce the first once-daily single tablet HIV regimen, Gilead Sciences has crossed the regulatory finish line with a new oral treatment option in…
